| # | Drug | Count |
|---|---|---|
| 0 | ROMIDEPSIN | 118 |
| 1 | CYCLOPHOSPHAMIDE | 103 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 103 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 103 |
| 4 | BRENTUXIMAB VEDOTIN | 92 |
| 5 | PREDNISONE | 82 |
| 6 | DOXORUBICIN | 80 |
| 7 | METHOTREXATE SODIUM | 65 |
| 8 | METHOTREXATE | 55 |
| 9 | PREDNISOLONE | 53 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROMIDEPSIN | 118 | 0.0699 |
| 1 | PRALATREXATE | 7 | 0.0108 |
| 2 | BRENTUXIMAB VEDOTIN | 92 | 0.0088 |
| 3 | LISOCABTAGENE MARALEUCEL | 5 | 0.0057 |
| 4 | CILTACABTAGENE AUTOLEUCEL | 16 | 0.0024 |
| 5 | DICLOXACILLIN SODIUM | 2 | 0.0022 |
| 6 | EPCORITAMAB-BYSP | 2 | 0.0015 |
| 7 | BENDAMUSTINE HCL | 19 | 0.0012 |
| 8 | DACARBAZINE | 9 | 0.0012 |
| 9 | BLEOMYCIN SULFATE | 12 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 92 | 0.0088 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 19 | 0.0049 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 11 | 0.0011 |
| 3 | Topoisomerase Inhibitor [EPC] | 46 | 0.0006 |
| 4 | Alkylating Drug [EPC] | 123 | 0.0005 |
| 5 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 6 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 9 | 0.0005 |
| 8 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |